These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 30336768)
1. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer. Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
3. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related]
4. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer. Huang Z; Yang Q; Huang Z Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580 [TBL] [Abstract][Full Text] [Related]
5. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis. Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105 [TBL] [Abstract][Full Text] [Related]
6. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis. Yu C; Chen F; Jiang J; Zhang H; Zhou M Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250 [TBL] [Abstract][Full Text] [Related]
7. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis. Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282 [TBL] [Abstract][Full Text] [Related]
8. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis. Li D; Yin Y; He M; Wang J Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701 [TBL] [Abstract][Full Text] [Related]
10. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
11. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling. Sun LC; Qian HX Mol Med Rep; 2018 Jun; 17(6):8260-8268. PubMed ID: 29658574 [TBL] [Abstract][Full Text] [Related]
12. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer. Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411 [TBL] [Abstract][Full Text] [Related]
13. Differentially Expressed Gene Screening, Biological Function Enrichment, and Correlation with Prognosis in Non-Small Cell Lung Cancer. Huang H; Huang Q; Tang T; Zhou X; Gu L; Lu X; Liu F Med Sci Monit; 2019 Jun; 25():4333-4341. PubMed ID: 31181055 [TBL] [Abstract][Full Text] [Related]
14. Bioinformatics methods for identifying differentially expressed genes and signaling pathways in nano-silica stimulated macrophages. Zhang L; Hao C; Li J; Qu Y; Bao L; Li Y; Yue Z; Zhang M; Yu X; Chen H; Zhang J; Wang D; Yao W Tumour Biol; 2017 Jun; 39(6):1010428317709284. PubMed ID: 28653889 [TBL] [Abstract][Full Text] [Related]
15. Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets. Wang JY; Huang JC; Chen G; Wei DM Mol Med Rep; 2018 Apr; 17(4):5013-5020. PubMed ID: 29393467 [TBL] [Abstract][Full Text] [Related]
16. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in Colorectal Cancer: Integrating Bioinformatics Analysis with Experimental Confirmation. Liu YM; Yang TC; Fang XC; Yang LJ; Shi LW; Wang HQ; Dou TT; Shu L; Chen TL; Hu J; Yu XM; Li XF Curr Med Sci; 2024 Jun; 44(3):529-544. PubMed ID: 38809379 [TBL] [Abstract][Full Text] [Related]
18. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer. Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326 [TBL] [Abstract][Full Text] [Related]
19. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer. Gao X; Yang J DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181 [TBL] [Abstract][Full Text] [Related]
20. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer. Yu C; Xue P; Zhang L; Pan R; Cai Z; He Z; Sun J; Zheng M World J Surg Oncol; 2018 Aug; 16(1):174. PubMed ID: 30134903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]